Maciej Niewada
Overview
Explore the profile of Maciej Niewada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
1701
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kupisz-Urbanska M, Jankowski P, Ceglowska U, Teisseyre P, Buszman P, Danilowicz-Szymanowicz L, et al.
Kardiol Pol
. 2025 Jan;
83(2):149-156.
PMID: 39743906
Background: Myocardial infarction (MI) remains the leading cause of death, especially in the elderly. Aims: To characterize management and factors related to event-free survival in patients with acute MI aged...
2.
Drozdz J, Morawiec R, Drozd M, Krzesinski P, Wozakowska-Kaplon B, Grabowski M, et al.
Kardiol Pol
. 2025 Jan;
PMID: 39743905
No abstract available.
3.
Kusmierczyk M, Witkowski A, Zembala M, Kapelak B, Gruchala M, Gackowski A, et al.
Cardiol J
. 2024 Nov;
31(6):895-905.
PMID: 39570007
Mitral regurgitation (MR) is the second most common valvular disease. Symptomatic MR is associated with a poor prognosis. Cardiac surgery is recommended in the severe form of the disease. If...
4.
Mela A, Lis D, Rdzanek E, Jaroszynski J, Furtak-Niczyporuk M, Drop B, et al.
Eur J Health Econ
. 2024 Oct;
26(1):143-146.
PMID: 39460843
No abstract available.
5.
Mela A, Tysarowski A, Rdzanek E, Blicharski T, Jaroszynski J, Furtak-Niczyporuk M, et al.
Expert Rev Pharmacoecon Outcomes Res
. 2024 Oct;
25(2):265-273.
PMID: 39431604
Background: To analyze the time from drug registration to reimbursement recommendations, we examined medicinal products, including new clinical indications, registered by the EMA between 2014 and 2019 across various therapeutic...
6.
Jakubczyk M, Bieganska J, Kowalczuk K, Jaworski R, Czech M, Pavelyev A, et al.
Ginekol Pol
. 2024 Oct;
96(2):119-125.
PMID: 39411820
Objectives: Human papillomavirus (HPV) is a prevalent sexually transmitted infection with significant implications for public health. In Poland, a nationwide vaccination program offers a choice between the 9-valent (9v) and...
7.
Macioch T, Krzakowski M, Golebiewska K, Dobek M, Warchalowska N, Niewada M
Discov Oncol
. 2024 Jul;
15(1):303.
PMID: 39048812
The efficacy of pembrolizumab in the treatment-naïve non-small-cell lung cancer (NSCLC) patients was proved in the KEYNOTE-024 randomized trial. The aim of this systematic literature review was to identify and...
8.
Lipska I, Di Bidino R, Niewada M, Nemeth B, Bochenek T, Kukla M, et al.
Healthcare (Basel)
. 2024 May;
12(9).
PMID: 38727447
The purpose of this article is to investigate the common facilitators and barriers associated with the implementation of hospital-based health technology assessment (HB-HTA) across diverse hospital settings in seven countries....
9.
Czech M, Augustynowicz E, Byliniak M, Jackowska T, Konstanty M, Kuchar E, et al.
Vaccines (Basel)
. 2024 Mar;
12(3).
PMID: 38543920
This study examines the vaccine market access pathway in Poland to evaluate its efficiency and propose recommendations for its improvement. The research spans a comprehensive analysis of the vaccine assessment...
10.
Mela A, Lis D, Rdzanek E, Jaroszynski J, Furtak-Niczyporuk M, Drop B, et al.
Eur J Health Econ
. 2024 Jan;
25(8):1291-1310.
PMID: 38261131
Our objective was to compare AOTMiT (Polish: Agencja Oceny Technologii Medycznych i Taryfikacji) recommendations to other HTA (Health Technology Assessment) agencies for newly registered drugs and new registration indications issued...